Wolfpack Investor Network Boosts Investment in Deep Blue Medical 

FOR IMMEDIATE RELEASE

Raleigh, NC – September 5, 2024 – The Wolfpack Investor Network (WIN) proudly announces a follow-on investment of $290K in Deep Blue Medical Advances, Inc. (Deep Blue), a medical technology company revolutionizing soft tissue surgery with cutting-edge technology that has already improved patient outcomes. 

Failures in soft tissue surgery, including hernia repairs, occur when pressures exceed the strength of the repair, leading to complications and high recurrence rates. In the U.S., these procedures are costly, with ventral hernia repairs costing approximately $10B annually. 

Founded in 2015, with operations in Durham, NC, and San Francisco, CA, Deep Blue has developed innovative soft tissue surgery products, including the T-Line® Hernia Mesh and T-Line® Tissue Control Suture. Leveraging intellectual property licensed from NC State, Deep Blue’s advancements aim to significantly reduce procedure time, lessen surgeon fatigue, minimize patient pain, and decrease the likelihood of requiring surgical remediation.

Robert Ross, partner at Harbright Ventures, WIN’s venture capital partner, stated, “Like many great innovations, at its core, Deep Blue applies a simple physics concept to leapfrog the performance of incumbent soft tissue surgeries. It is unacceptable that 30% of abdominal hernia repairs fail. WIN and Harbright are happy to reinvest in Deep Blue to play our part in bringing T-Line^Ⓡ products to practitioners and patients in need of longer-lasting solutions.” 

WIN recently celebrated Deep Blue’s receipt of the prestigious Luis Villalobos Award from the Angel Capital Association for excellence in innovation and impact in the Life Sciences category.

“We are thrilled to have WIN and Harbright’s continued support with this new round of funding,” said Bill Perry, CEO of Deep Blue. “WIN and Harbright’s investments are a testament to their belief in our mission and our innovative approach to soft tissue surgery. This funding will enable us to accelerate the development and commercialization of our groundbreaking products, ultimately improving patient outcomes on a larger scale. We deeply appreciate WIN and Harbright’s confidence in our vision and their commitment to helping us achieve it.”

Deep Blue marks the latest investment by WIN, a member-based investment group composed of NC State alumni and friends advancing university-tied companies.

About Deep Blue

Deep Blue enhances patient outcomes by revolutionizing soft tissue surgery with next-generation surgical devices. Their patented solutions reinforce stability and reduce surgical site stress, preventing failures such as hernia repair and breast surgery complications.

About WIN
WIN bridges the gap between NC State alums, faculty, friends, and promising startups, offering mentorship, resources, and capital to nurture the growth and success of ventures connected to NC State. Since its inception in 2017, WIN has invested over $25M in 36 portfolio companies.